Koyfin Home > Directory > Health Care > Adma Biologics > Return on Capital %

Adma Biologics Return on Capital % Chart (ADMA)

Adma Biologics annual/quarterly Return on Capital % from 2011 to 2020.
  • Adma Biologics Return on Capital % for the quarter ending June 06, 2020 was -23.07 a 21.97% decrease of -5.07 year over year
  • Adma Biologics Return on Capital % for the last 12 months ending June 06, 2020 was -20.64 a -52.76% increase of 10.89 year over year
  • Adma Biologics Annual Return on Capital % for 2019 was -30.08 a -76.73% increase of 23.08 from 2018
  • Adma Biologics Annual Return on Capital % for 2018 was -53.15 a -1.92% increase of 1.02 from 2017
  • Adma Biologics Annual Return on Capital % for 2017 was -54.18 a -37.44% increase of 20.28 from 2016
Other Margins & Efficiency Metrics:
  • Adma Biologics EBITDA Margin for the quarter ending June 06, 2018 was $-270m a 24.55% decrease of -66m year over year
  • Adma Biologics Return on Equity % for the quarter ending September 09, 2018 was -136.10 a -43.11% increase of 58.67 year over year
View Chart On Koyfin

Quarterly ADMA Return on Capital % Data

06/2020-23.07
03/2020-27.45
12/2019-16.91
09/2019-18.00
06/2019-28.58
03/2019-51.31
12/2018-59.26
09/2018-40.32
06/2018-42.96
03/2018-57.39

Annual ADMA Return on Capital % Data

2019-30.08
2018-53.15
2017-54.18
2016-74.46
2015-54.23
2014-42.46
2013-47.24
2012-69.52
2011-79.38
2010-68.12